Claassen M - Search Results

1

Protease inhibitor resistance in South African children with virologic failure.

van Zyl GU, van der Merwe L, Claassen M, Cotton MF, Rabie H, Prozesky HW, Preiser W. van Zyl GU, et al. Among authors: claassen m. Pediatr Infect Dis J. 2009 Dec;28(12):1125-7. doi: 10.1097/INF.0b013e3181af829d. Pediatr Infect Dis J. 2009. PMID: 19779394

2

Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa.

Claassen M, van Zyl GU, Korsman SN, Smit L, Cotton MF, Preiser W. Claassen M, et al. J Clin Virol. 2006 Sep;37(1):68-71. doi: 10.1016/j.jcv.2006.06.008. Epub 2006 Jul 27. J Clin Virol. 2006. PMID: 16875874

3

Extraction buffer contaminated bacterially as a cause of invalid HIV-1 viral load results on the NucliSens EasyQ system.

Claassen M, van Zyl GU, Preiser W. Claassen M, et al. J Virol Methods. 2008 Jun;150(1-2):80-1. doi: 10.1016/j.jviromet.2008.03.004. Epub 2008 Apr 18. J Virol Methods. 2008. PMID: 18423634

4

Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.

van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, Theron GB, Preiser W. van Zyl GU, et al. Among authors: claassen m. J Med Virol. 2008 Jun;80(6):942-6. doi: 10.1002/jmv.21157. J Med Virol. 2008. PMID: 18428139

5

Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa.

van Zyl GU, Cotton MF, Claassen M, Abrahams C, Preiser W. van Zyl GU, et al. Among authors: claassen m. Pediatr Infect Dis J. 2010 Apr;29(4):370-1. doi: 10.1097/INF.0b013e3181c4dada. Pediatr Infect Dis J. 2010. PMID: 19935449

6

Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.

van Zyl GU, van der Merwe L, Claassen M, Zeier M, Preiser W. van Zyl GU, et al. Among authors: claassen m. J Med Virol. 2011 Oct;83(10):1764-9. doi: 10.1002/jmv.22189. J Med Virol. 2011. PMID: 21837793

7

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.

Van Zyl GU, Liu TF, Claassen M, Engelbrecht S, de Oliveira T, Preiser W, Wood NT, Travers S, Shafer RW. Van Zyl GU, et al. Among authors: claassen m. PLoS One. 2013 Jun 26;8(6):e67188. doi: 10.1371/journal.pone.0067188. Print 2013. PLoS One. 2013. PMID: 23840622 Free PMC article.

8

Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa.

Neogi U, Engelbrecht S, Claassen M, Jacobs GB, van Zyl G, Preiser W, Sonnerborg A. Neogi U, et al. Among authors: claassen m. AIDS Res Hum Retroviruses. 2016 Jan;32(1):80-4. doi: 10.1089/AID.2015.0266. Epub 2015 Oct 9. AIDS Res Hum Retroviruses. 2016. PMID: 26413747

9

Moderate levels of pre-therapy drug resistance (PDR) in a generalised epidemic: time for better first-line ART?

van Zyl GU, Grobbelaar CJ, Claassen M, Bock P, Preiser W. van Zyl GU, et al. Among authors: claassen m. AIDS. 2017 Nov;31(17):2387-2391. doi: 10.1097/QAD.0000000000001629. Epub 2017 Aug 28. AIDS. 2017. PMID: 28857824

10

Resistance in patients failing integrase strand transfer inhibitors: a call to replace raltegravir with dolutegravir in third-line treatment in South Africa.

Steegen K, van Zyl G, Letsoalo E, Claassen M, Hans L, Carmona S. Steegen K, et al. Among authors: claassen m. Open Forum Infect Dis. 2019 Aug 21;6(10):ofz377. doi: 10.1093/ofid/ofz377. Online ahead of print. Open Forum Infect Dis. 2019. PMID: 31433056 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters